News June 2021

A peer reviewed scientific publication (De Smit et al. 2021) is now available reporting the research performed by Smivet on the development of a life saving new and innovative Tetanus Antitoxin. It is a bivalent bispecific trimer single-domain antibody. The commercial product which is in the final phase of development will replace the animal serum derived product for which hundreds of animals are used worldwide every year. You can read or download the scientific publication here.